Back
Century Therapeutics, Inc. 10K Form
Sell
21
IPSC
Century Therapeutics, Inc.
Last Price:
$0.57
Seasonality Move:
-30.11%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive IPSC News And Ratings
See the #1 stock for the next 7 days that we like better than IPSC
IPSC Financial Statistics
Sales & Book Value
| Annual Sales: | $6.6M |
|---|---|
| Cash Flow: | $-25.8M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.04 |
| Price / Book: | 0.26 |
Profitability
| EPS (TTM): | -0.31090 |
|---|---|
| Net Income (TTM): | $-26.5M |
| Gross Margin: | $-6.7M |
| Return on Equity: | -13.46% |
| Return on Assets: | -8.34% |
Century Therapeutics, Inc. Earnings Forecast
Key Century Therapeutics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 6 years for IPSC is -101.91%.
-
The Selling, General & Administrative Expenses for IPSC have been equal to 503.19% of Gross Profit Margin.
-
The Research & Development expenses have been 1,627.62% of Revenue.
-
The Net Earning history of IPSC is -1,920.87% of Total Revenues.
-
Per Share Earnings over the last 8 years have been positive in 2 years.
Century Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | IPSC |
| Website: | centurytx.com |
Debt
| Debt-to-Equity Ratio: | 0.25 |
|---|---|
| Current Ratio: | 6.25 |
| Quick Ratio: | 6.03 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
IPSC Technical Analysis vs Fundamental Analysis
Sell
21
Century Therapeutics, Inc. (IPSC)
is a Sell
Is Century Therapeutics, Inc. a Buy or a Sell?
-
Century Therapeutics, Inc. stock is rated a SellThe current Century Therapeutics, Inc. [IPSC] share price is $0.53. The Score for IPSC is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.